Drug Type Small molecule drug |
Synonyms |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists), 5-HT6 receptor antagonists(Serotonin 6 (5-HT6) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19ClN4O2S |
InChIKeyMUFITXOADYQFSV-UHFFFAOYSA-N |
CAS Registry1648745-45-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | PL | 05 Oct 2023 |